l suit over its allegedly fraudulent overbilling. Order attached I Read full article Intercept Beats Investor Suit Over Liver Disease Drug Deaths Intercept Pharmaceuticals Inc. on Thursday exited a proposed securities class action accusing it of covering up reports of fatalities and injuries caused by a liver disease drug,